5M7E
Tubulin-BKM120 complex
5M7E の概要
| エントリーDOI | 10.2210/pdb5m7e/pdb |
| 関連するPDBエントリー | 4O2B |
| 分子名称 | Tubulin alpha-1B chain, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine, ... (13 entities in total) |
| 機能のキーワード | cell cycle, tubulin fold, cytoskeleton, microtubule |
| 由来する生物種 | Rattus norvegicus (Rat) 詳細 |
| 細胞内の位置 | Cytoplasm, cytoskeleton: P81947 Q6B856 Golgi apparatus : P63043 |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 265192.96 |
| 構造登録者 | Bohnacker, T.,Prota, A.E.,Steinmetz, M.O.,Wymann, M.P. (登録日: 2016-10-27, 公開日: 2017-02-22, 最終更新日: 2024-01-17) |
| 主引用文献 | Bohnacker, T.,Prota, A.E.,Beaufils, F.,Burke, J.E.,Melone, A.,Inglis, A.J.,Rageot, D.,Sele, A.M.,Cmiljanovic, V.,Cmiljanovic, N.,Bargsten, K.,Aher, A.,Akhmanova, A.,Diaz, J.F.,Fabbro, D.,Zvelebil, M.,Williams, R.L.,Steinmetz, M.O.,Wymann, M.P. Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nat Commun, 8:14683-14683, 2017 Cited by PubMed Abstract: BKM120 (Buparlisib) is one of the most advanced phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of cancer, but it interferes as an off-target effect with microtubule polymerization. Here, we developed two chemical derivatives that differ from BKM120 by only one atom. We show that these minute changes separate the dual activity of BKM120 into discrete PI3K and tubulin inhibitors. Analysis of the compounds cellular growth arrest phenotypes and microtubule dynamics suggest that the antiproliferative activity of BKM120 is mainly due to microtubule-dependent cytotoxicity rather than through inhibition of PI3K. Crystal structures of BKM120 and derivatives in complex with tubulin and PI3K provide insights into the selective mode of action of this class of drugs. Our results raise concerns over BKM120's generally accepted mode of action, and provide a unique mechanistic basis for next-generation PI3K inhibitors with improved safety profiles and flexibility for use in combination therapies. PubMed: 28276440DOI: 10.1038/ncomms14683 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.046 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






